Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449342 | PMC |
| http://dx.doi.org/10.1007/s12307-015-0165-y | DOI Listing |
Publication Analysis
Top Keywords
erratum biomodulatory
4
biomodulatory treatment
4
treatment patients
4
patients castration-resistant
4
castration-resistant prostate
4
prostate cancer
4
cancer phase
4
phase study
4
study imatinib
4
imatinib pioglitazone
4
Similar Publications
Erratum to: Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan.
Cancer Microenviron
April 2015
Department of Hematology and Oncology, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!